Replies to post #25959 on BioCurex, Inc.(fka BOCX)

[gaboy47]

<Yes, that is the one difference in the company. The next question is if it is a good idea to attempt to self market a product when a large company like Abbott has passed on the product.>

There is no documentation anywhere that Abbott has passed on Recaf completely. Key word here is completely. I know they had temporarily ceased work with Recaf for their automated analyzer. You stated before the person tasked to take this project at Abbott left and you implied he was fired. If Abbott fired this guy as you claim, don't you think Abbott would have returned the license to Biocurex, which they have not. When Aboott returns the license only then will I believe Abbott no longer has any interest in Recaf for any application. Do you really think Abbott would be part of a scam by Dr. Moro as you claim for the past two years. The SEC would also tear Abbott apart.

All indication is that Abbott is working in conjunction with Inverness to commercialize Recaf. The direction of Biocurex has changed from diagnostics to monitoring which also is an enourmous market.